A Pfizer clinical trial on pregnant women has revealed a staggering 420% increase in congenital abnormalities and developmental delays among newborns linked to COVID vaccines, raising serious concerns about their safety during pregnancy.

The recently updated Pfizer clinical trial, “To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women” (ClinicalTrials.gov ID NCT04754594), has sparked renewed scrutiny after revealing a significant increase in congenital abnormalities among newborns of vaccinated participants.

The study assessed outcomes in 348 healthy pregnant women randomized to receive either the COVID-19 vaccine or a placebo during their third trimester. Findings indicate that children born to vaccinated mothers experienced a 4.2x higher rate of adverse events of special interest (AESIs), including major congenital abnormalities and developmental delays, within the first six months of life.

The effect size reached a 90% level of statistical significance, a threshold often considered suggestive but not definitive in medical research. While the trial’s smaller-than-planned enrollment may have limited its ability to achieve greater statistical power, experts note that a 4.2x increase in such severe outcomes is extraordinary and deeply concerning.

Equally troubling, the vaccine showed little to no benefit in preventing COVID-19 among participants. Both vaccinated and placebo groups reported two cases of COVID-19, resulting in an estimated vaccine efficacy of just 3.8%, a figure described as statistically insignificant.

Despite the trial results being publicly available for over five months, there has been no formal acknowledgment or warning from the CDC or mainstream medical organizations.

Not a single mainstream doctor is speaking out about the dangers of the vaccine for newborns.

How did Pfizer manage to keep this information under the radar? By simply opting not to issue a press release!

As expected, the mainstream media failed to investigate or report on these findings, underscoring deeper systemic issues within the medical and regulatory establishment—where corporate sponsorships and advertising revenue take precedence over public accountability.

Dr. James Thorp, a physician outspoken about vaccine risks in pregnancy, has highlighted these findings in recent peer-reviewed research.

The conclusion of Dr. James Thorp’s most recent published paper (“Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the U.S. Government,Medical Organizations, and Pharmaceutical Industry Claim?”)

Dr. Thorp was ousted from the medical establishment after raising valid concerns about vaccine safety. This highlights a pervasive climate of fear and the suppression of dissenting voices within Big Pharma and the medical industry.

The trial’s implications could not be more serious. Combined with corroborating data from independent studies, serious questions must be raised about the medical community’s response to these findings.

The 4.2x increased risk of severe outcomes among newborns calls for immediate transparency, further investigation, and a reevaluation of vaccine recommendations for pregnant women.

If a society does not protect its children, it jeopardizes its future, undermining the very foundation of its moral and social fabric.